The goal of this activity is for learners to be better able to understand the latest clinical developments regarding B-cell modulating therapies with dual inhibition in immunoglobulin A (IgA) nephropathy.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.25 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 1,252 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Clinical Informatics
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Obstetrics & Gynecology
- Ophthalmology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Neurology
- Plastic & Reconstructive Surgery
- Preventive Medicine
- Primary Care Sports Medicine
- Pulmonary Disease
- Rheumatology
- Rhinology
- Sleep Medicine
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Blended / Other
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedNov 5, 2025
-
Last day to claim creditNov 6, 2026 4 weeks left
-
Medscape, LLC The ASN 2025 Clinical Snapshot: Catch Up With the Latest in IgAN and the B-Cell Pathway
-
Medscape, LLC New Frontiers in IgA Nephropathy: Understanding the Role of B-Cell Modulation
-
Medscape, LLC A New Chapter in IgA Nephropathy Care: Applying Evidence-Based Practices for B-Cell-Modulating Therapies
-
National Kidney Foundation Immunology in Action: Exploring B-Cell Directed Therapies for IgA Nephropathy
-
PRIME Education, Inc. (PRIME®) New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications
-
PeerVoice, Siyemi Europe Limited PeerVoice – 2025 Congress Highlights From Houston, Texas: A Fresh Look At The Data Driving Targeted Therapeutic Developments In IgA Nephropathy
